α-Galactosidase-A Loaded-Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration-Reference-Cited by-同舟云学术

α-Galactosidase-A Loaded-Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration

Published:2016-02-18 Issue:7 Volume:5 Page:829-840
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Cabrera Ingrid¹²,Abasolo Ibane²³,Corchero José L.²⁴,Elizondo Elisa¹²,Gil Pilar Rivera¹²,Moreno Evelyn¹²,Faraudo Jordi¹,Sala Santi¹²,Bueno Dolores¹²,González-Mira Elisabet¹²,Rivas Merche⁵,Melgarejo Marta²⁶,Pulido Daniel²⁶,Albericio Fernando²⁷⁸,Royo Miriam²⁶,Villaverde Antonio²⁴,García-Parajo Maria F.⁵⁹,Schwartz Simó²³,Ventosa Nora¹²,Veciana Jaume¹²

Affiliation:

1. Institut de Ciència de Materials de Barcelona (ICMAB-CSIC); Campus Universitari de Bellaterra; 08193 Cerdanyola del Vallès Spain

2. Centro de Investigación Biomédica en Red-Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN); Spain

3. CIBBIM-Nanomedicine; Vall d'Hebron Institut de Recerca (VHIR); Universitat Autònoma de Barcelona; 08035 Barcelona Spain

4. Departament de Genètica i de Microbiologia; Institut de Biotecnologia i de Biomedicina; Universitat Autònoma de Barcelona; 08193 Bellaterra Spain

5. ICFO-Institut de Ciencies Fotoniques; Mediterranean Technology Park; 08860 Castelldefels Barcelona Spain

6. Combinatorial Chemistry Unit; Barcelona Science Park; Baldiri Reixac 10 08028 Barcelona Spain

7. Institute for Research in Biomedicine; Barcelona Science Park; 08028 Barcelona Spain

8. Department of Organic Chemistry; University of Barcelona; 08028 Barcelona Spain

9. ICREA-Institució Catalana de Recerca i Estudis Avançats; 08010 Barcelona Spain

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Reference49 articles.

1. Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy

2. Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease

3. Enzyme Replacement Therapy for Fabry Disease

4. Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders;Advanced Drug Delivery Reviews;2023-06

2. Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function;Advanced Drug Delivery Reviews;2023-06

3. How a few help all: cooperative crossing of lipid membranes by COSAN anions;Physical Chemistry Chemical Physics;2023

4. Recent advances of graphene–biomacromolecule nanocomposites in medical applications;Journal of Materials Chemistry B;2023

5. Background of carbon nanotubes for drug delivery systems;Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery;2023